Innate Pharma SA/ FR0010331421 /
| 2024-06-10 5:35:13 PM | Chg. -0.095 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 2.440EUR | -3.75% | 83,314 Turnover: 204,599.125 |
2.420Bid Size: 1,183 | 2.460Ask Size: 35 | 2.530 | 2.400 |
GlobeNewswire
04-25
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire
2022-02-04
Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
GlobeNewswire
2021-11-09
Noema Pharma expands its Board of Directors with the appointments of Catherine Moukheibir and Ilise ...
GlobeNewswire
2021-09-23
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
GlobeNewswire
2021-09-15
Innate Pharma Reports First Half 2021 Financial Results and Business Update
GlobeNewswire
2021-09-07
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
GlobeNewswire
2021-09-02
Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress
GlobeNewswire
2021-07-06
Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
GlobeNewswire
2021-06-22
Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab ...
GlobeNewswire
2021-06-16
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
GlobeNewswire
2021-06-10
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Mee...
GlobeNewswire
2021-06-09
New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th Interna...
GlobeNewswire
2021-06-09
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th Interna...
GlobeNewswire
2021-05-04
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
GlobeNewswire
2021-05-04
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
